Clemastine Ameliorates Perioperative Neurocognitive Disorder in Aged Mice Caused by Anesthesia and Surgery

Abstract

Perioperative neurocognitive disorder (PND) leads to progressive deterioration of cognitive function, especially in aged patients. Demyelination is closely associated with cognitive dysfunction. However, the relationship between PND and demyelination remains unclear. Here we showed that demyelination was related to the pathogenesis of PND. Clemastine, an antihistamine with potency in remyelination, was predicted to have a potential therapeutic effect on PND by next-generation sequencing and bioinformatics in our previous study. In the present study, it was given at 10 mg/kg per day for 2 weeks to evaluate the effects on PND in aged mice. We found that clemastine ameliorated PND and reduced the expression levels of inflammatory factors such as tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β). Further investigation suggested clemastine increased the expression of oligodendrocyte transcription factor 2 (OLIG2) and myelin basic protein (MBP) to enhance remyelination by inhibiting the overactivation of the WNT/β-catenin pathway. At the same time, the expression of post-synaptic density protein 95 (PSD95, or DLG4), brain-derived neurotrophic factor (BDNF), synaptosomal-associated protein 25 (SNAP25) and neuronal nuclei (NEUN) were also improved. Our results suggested that clemastine might be a therapy for PND caused by anesthetic and surgical factors in aged patients.

Discovery of Novel Drug Candidates for Alzheimer’s Disease by Molecular Network Modeling

“…Firstly, CMap collects transcriptional profiles from human cell lines treated with smallmolecule compounds and we cannot exclude the possibility that restoration of dysregulated gene expression after being treated with drug candidates may not apply to human disease tissues, especially in non-cancerous diseases. Even so, Cmap has been proved useful in predicting potential drug candidates for subsequent experimental validation in some brain diseases including Parkinson's disease (Gao et al, 2014), ischemic stroke (Luo et al, 2019), and perioperative neurocognitive disorder (Wu et al, 2021). Secondly, since GHK was predicted by network-based drug discovery, we cannot exclude the possibility that GHK may show reactivity to additional off-targets besides primary targets, perturb unintended signaling pathways and finally cause side effects.…”

Transcranial near-infrared laser improves postoperative neurocognitive disorder in aged mice via SIRT3/AMPK/Nrf2 pathway

“…In addition, neuroinflammation and oxidative stress influence neurotrophic factors, especially BDNF, which can increase synaptic plasticity and neurogenesis ( Gardiner et al, 2009 ; Wang et al, 2020 ). Our previous studies have shown that the lower level of the synaptic proteins, i.e., PSD95, SYP, and BDNF, is closely related to cognitive impairment ( Wu et al, 2021 ). In the present study, we found that the expression levels of SYP, PSD95, and BDNF were downregulated in the hippocampus of PND mice, and TNIL treatment ameliorated these phenomena.…”

Mast cell stabilizer disodium cromoglycate improves long-term cognitive impairment after general anesthesia exposure in neonatal mice

“…Twenty-four hours after NOR test, mice were subjected to Barnes maze to test their short-term and long-term spatial learning and memory as previous studies ( Wu W. et al, 2021 ). Barnes maze is a circular platform with 20 equally spaced holes (Anhui Zhenghua Biological Instrument equipments Co., Ltd., Anhui, China).…”